JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 3 filers reported holding JUNO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,055,857,000 | 100.00% |
| Omega Fund Management, LLC | 1,329,512 | $54,098,000 | 30.46% |
| SOUND ENERGY PARTNERS, INC. | 25,800 | $1,050,000 | 2.12% |
| Graticule Asia Macro Advisors LLC | 435,205 | $17,708,000 | 2.06% |
| BB BIOTECH AG | 1,305,000 | $53,100,000 | 1.68% |
| Kazazian Asset Management, LLC | 13,376 | $544,000 | 0.69% |
| Rock Springs Capital Management LP | 197,001 | $8,016,000 | 0.65% |
| TURNER INVESTMENTS LLC | 69,680 | $2,835,000 | 0.57% |
| MIZUHO SECURITIES USA LLC | 49,600 | $2,018,000 | 0.52% |
| Private Capital Advisors, Inc. | 27,900 | $1,135,000 | 0.48% |